therapeutic action: Glucan synthase inhibition

Identification and antifungal susceptibility patterns of reference yeast strains to novel and conventional agents: a comparative study using CLSI, EUCAST and Sensititre YeastOne methods

Researchers compared three different laboratory methods for testing how well antifungal drugs work against common yeast infections. They tested 22 different yeast strains including Candida species using CLSI, EUCAST, and Sensititre YeastOne methods. The methods showed strong agreement overall, but some newer antifungal drugs like ibrexafungerp showed more variation between methods. The findings suggest these methods are reliable for guiding treatment decisions, but further standardization is needed for newer drugs.

Read More »

Breaking down the wall: Solid-state NMR illuminates how fungi build and remodel diverse cell walls

Scientists have developed a new technique called solid-state NMR that can examine fungal cell walls without damaging them, revealing how these structures are built and reorganized. This research shows that different fungi have different wall architectures made of sugar-like molecules including chitin and various glucans, and that fungi can quickly adapt their walls when exposed to antifungal drugs. These findings could help develop better antifungal treatments by targeting the specific structural features that different fungi rely on for survival.

Read More »
Scroll to Top